Pembrolizumab-pmph 395 mg / berahyaluronidase alfa-pmph 4800 UNT in 2.4 mL Injection
RxNorm 2723762
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2723762 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: pembrolizumab-pmph 395 mg / berahyaluronidase alfa-pmph 4800 UNT in 2.4 mL Injection.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
2.4 mL berahyaluronidase alfa-pmph 2000 UNT/ML / pembrolizumab-pmph 165 mg/ML Injection
(Atom ID: 12999683)
PSNPrescribable
Prescribable Name (PSN):
Pembrolizumab-pmph 395 mg / berahyaluronidase alfa-pmph 4800 UNT in 2.4 mL Injection
(Atom ID: 12999695)
SYPrescribable